Biopharma services company Allucent has announced that it has named Katy Moore to lead a team of pharmacometricians to create custom modeling and simulation approaches for clinical trial designs. Moore’s official title will be president of clinical pharmacology, modeling and simulation (CPMS). “What inspired me to join Allucent was the opportunity to work for a…